Status:
RECRUITING
Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Mesothelioma, Malignant
Gene Abnormality
Eligibility:
All Genders
18-95 years
Brief Summary
Malignant pleural mesothelioma (MPM) is a rare pleural cancer, which could be primary or secondary to an asbestos exposure. To enhance our knowledge of this rare disease, an exploration of genetic and...
Eligibility Criteria
Inclusion
- age \>18
- suspected MPM requiring VATS biopsy after multidisciplinary oncologic board validation
- patient able to understand study objectives and able to give an informed consent
- patient affiliated to an healthcare society.
Exclusion
- pregnancy
- mental disease, psychiatric disorder
- patient under protection regimen
Key Trial Info
Start Date :
February 11 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 11 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04823741
Start Date
February 11 2022
End Date
February 11 2026
Last Update
February 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Département de chirurgie thoracique
Bron, France, 69677